Cargando…

Modification of phosphoinositides by the Shigella effector IpgD during host cell infection

Shigella, the causative agent of bacillary dysentery, subvert cytoskeletal and trafficking processes to invade and replicate in epithelial cells using an arsenal of bacterial effectors translocated through a type III secretion system. Here, we review the various roles of the type III effector IpgD,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran Van Nhieu, Guy, Latour-Lambert, Patricia, Enninga, Jost
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647168/
https://www.ncbi.nlm.nih.gov/pubmed/36389142
http://dx.doi.org/10.3389/fcimb.2022.1012533
_version_ 1784827327436292096
author Tran Van Nhieu, Guy
Latour-Lambert, Patricia
Enninga, Jost
author_facet Tran Van Nhieu, Guy
Latour-Lambert, Patricia
Enninga, Jost
author_sort Tran Van Nhieu, Guy
collection PubMed
description Shigella, the causative agent of bacillary dysentery, subvert cytoskeletal and trafficking processes to invade and replicate in epithelial cells using an arsenal of bacterial effectors translocated through a type III secretion system. Here, we review the various roles of the type III effector IpgD, initially characterized as phosphatidylinositol 4,5 bisphosphate (PI4,5P(2)) 4-phosphatase. By decreasing PI4,5P(2) levels, IpgD triggers the disassembly of cortical actin filaments required for bacterial invasion and cell migration. PI5P produced by IpgD further stimulates signaling pathways regulating cell survival, macropinosome formation, endosomal trafficking and dampening of immune responses. Recently, IpgD was also found to exhibit phosphotransferase activity leading to PI3,4P(2) synthesis adding a new flavor to this multipotent bacterial enzyme. The substrate of IpgD, PI4,5P(2) is also the main substrate hydrolyzed by endogenous phospholipases C to produce inositoltriphosphate (InsP(3)), a major Ca(2+) second messenger. Hence, beyond the repertoire of effects associated with the direct diversion of phoshoinositides, IpgD indirectly down-regulates InsP(3)-mediated Ca(2+) release by limiting InsP(3) production. Furthermore, IpgD controls the intracellular lifestyle of Shigella promoting Rab8/11 -dependent recruitment of the exocyst at macropinosomes to remove damaged vacuolar membrane remnants and promote bacterial cytosolic escape. IpgD thus emerges as a key bacterial effector for the remodeling of host cell membranes.
format Online
Article
Text
id pubmed-9647168
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96471682022-11-15 Modification of phosphoinositides by the Shigella effector IpgD during host cell infection Tran Van Nhieu, Guy Latour-Lambert, Patricia Enninga, Jost Front Cell Infect Microbiol Cellular and Infection Microbiology Shigella, the causative agent of bacillary dysentery, subvert cytoskeletal and trafficking processes to invade and replicate in epithelial cells using an arsenal of bacterial effectors translocated through a type III secretion system. Here, we review the various roles of the type III effector IpgD, initially characterized as phosphatidylinositol 4,5 bisphosphate (PI4,5P(2)) 4-phosphatase. By decreasing PI4,5P(2) levels, IpgD triggers the disassembly of cortical actin filaments required for bacterial invasion and cell migration. PI5P produced by IpgD further stimulates signaling pathways regulating cell survival, macropinosome formation, endosomal trafficking and dampening of immune responses. Recently, IpgD was also found to exhibit phosphotransferase activity leading to PI3,4P(2) synthesis adding a new flavor to this multipotent bacterial enzyme. The substrate of IpgD, PI4,5P(2) is also the main substrate hydrolyzed by endogenous phospholipases C to produce inositoltriphosphate (InsP(3)), a major Ca(2+) second messenger. Hence, beyond the repertoire of effects associated with the direct diversion of phoshoinositides, IpgD indirectly down-regulates InsP(3)-mediated Ca(2+) release by limiting InsP(3) production. Furthermore, IpgD controls the intracellular lifestyle of Shigella promoting Rab8/11 -dependent recruitment of the exocyst at macropinosomes to remove damaged vacuolar membrane remnants and promote bacterial cytosolic escape. IpgD thus emerges as a key bacterial effector for the remodeling of host cell membranes. Frontiers Media S.A. 2022-10-27 /pmc/articles/PMC9647168/ /pubmed/36389142 http://dx.doi.org/10.3389/fcimb.2022.1012533 Text en Copyright © 2022 Tran Van Nhieu, Latour-Lambert and Enninga https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Tran Van Nhieu, Guy
Latour-Lambert, Patricia
Enninga, Jost
Modification of phosphoinositides by the Shigella effector IpgD during host cell infection
title Modification of phosphoinositides by the Shigella effector IpgD during host cell infection
title_full Modification of phosphoinositides by the Shigella effector IpgD during host cell infection
title_fullStr Modification of phosphoinositides by the Shigella effector IpgD during host cell infection
title_full_unstemmed Modification of phosphoinositides by the Shigella effector IpgD during host cell infection
title_short Modification of phosphoinositides by the Shigella effector IpgD during host cell infection
title_sort modification of phosphoinositides by the shigella effector ipgd during host cell infection
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647168/
https://www.ncbi.nlm.nih.gov/pubmed/36389142
http://dx.doi.org/10.3389/fcimb.2022.1012533
work_keys_str_mv AT tranvannhieuguy modificationofphosphoinositidesbytheshigellaeffectoripgdduringhostcellinfection
AT latourlambertpatricia modificationofphosphoinositidesbytheshigellaeffectoripgdduringhostcellinfection
AT enningajost modificationofphosphoinositidesbytheshigellaeffectoripgdduringhostcellinfection